NGT3

Early-stage medical device and life sciences venture capital fund and technology incubator based in Nazareth, Israel.

Incubator Nazareth, Israel Est. 2013
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
6
in our dataset
Rounds participated
7
Rounds led
1
Rounds' value
$7.1M
total disclosed, rounds participated
Stages
Seed, Pre-Seed

About

NGT3 (Next Generation Technology) is an early-stage investment entity structured as a venture capital fund, focused on medical device and life science technologies. It operates as an Israeli government-licensed technological incubator, encouraging Arab and Jewish entrepreneurship. NGT3 is the next generation of NGT, which operated as a technological incubator since 2002. It focuses on a "triple bottom line" by developing cutting-edge medical technologies, providing high financial returns, and fostering a social agenda of inclusion and multicultural collaboration. NGT3 enjoys significant leverage through non-dilutive grants from Israel's Innovation Authority (formerly the Office of the Chief Scientist).

Portfolio · 6

OTTek
Colonoscopy Assist Device
1 round Latest: 2020-01
EIO Biomedical
Postsurgical Adhesion Prevention
2 rounds $1.5M committed Latest: 2019-01
ParaSonic
Ultrasound Device for the Elimination of Lice
1 round $800K committed Latest: 2015-04
PamBio
Antifibrinolytic Therapy for Acute Bleeding Conditions
1 round $3.0M committed Latest: 2015-01
Synnerva
Central Nervous System Drug Composition
Led ★ 1 round $500K committed
Aqueduct Medical
Cervical Dilator Device
1 round $1.3M committed

Investment activity

Portfolio by sector

Health Tech & Life Sciences23
Aerospace, Defense & HLS1

Q&A

What is NGT3's primary investment focus?
NGT3 primarily invests in early-stage technology-based startup companies with a social agenda, focusing on innovative medical devices and life sciences. They also encourage Arab and Jewish entrepreneurship.
What investment stages does NGT3 target?
NGT3 targets Seed and Pre-Seed investment stages.
Can you name some of NGT3's portfolio companies?
NGT3's portfolio includes companies such as Nurami Medical, which raised $43.65M for modernizing soft tissue repair, and Virility Medical, which raised $21M for a skin patch for the treatment of premature ejaculation.
What is NGT3's geographic focus for investments?
NGT3 is rooted in Nazareth, Israel, and focuses on new opportunities while fostering a social agenda of inclusion and multicultural collaboration within the region.
Who are the key managing partners at NGT3?
The key managing partners at NGT3 are Zohar Gendler, CEO & Managing Partner, and Nizar Mishael, CFO & Managing Partner.
What is the most recent investment round identified for a NGT3 portfolio company?
In August 2021, NGT3 participated in an investment round for a portfolio company.
What is NGT3's historical background?
NGT3 is the next generation of NGT, which operated as a technological incubator since 2002. Its operation continues today under the name NGT HealthCare II.
What is NGT3's approach to investment beyond financial returns?
NGT3 focuses on a triple bottom line: developing and creating value for cutting-edge medical technologies, providing high financial returns for its partners and investors, and fostering a social agenda of inclusion and multicultural collaboration.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)